Drs Camidge and Rimel spotlight Dr Rimel’s career journey and the work she does to expand medical care for transgender patients.
BJ Rimel, MD
Advertisement
Articles by BJ Rimel, MD
BJ Rimel, MD, discuss the current literature surrounding antiangiogenesis agents in ovarian cancer.
Advertisement
Latest Updated Articles
Antiangiogenesis Agents in Ovarian CancerMarch 29th 2015
Advertisement
Advertisement
Trending on OncLive
1
Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings
2
Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026
3
In Vivo CAR T-Cell Therapy Drives Responses and MRD Negativity in R/R Myeloma
4
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer
5